The article describes strategy for masking the intensely bitter taste of Azithromycin Dihydrate (AZT) by using complexation with Kyron T-134. The resinates prepared with drug-Kyron T-134 ratio (1:3) at pH 8, gave maximum drug loading. Suspension containing, resinate showed more than 90% invitro drug release within 45min. Prepared formulation showed good stability and retention of palatable taste. Thus, the "patient-friendly dosage form" of bitter drugs, especially for pediatric, geriatric, bedridden, and non cooperative patients, can be successfully formulated using this technology.
Introduction
The problem of providing pediatric and geriatric patient with drug dosage forms that are palatable has been around for long time. Children and infants in particular, are most sensitive to bitter and sweet tastes than adults. Different taste masking technologies have been used to address the problem of patient compliance. Conventional taste masking techniques such as the use of sweeteners, amino acids and flavoring agents alone are often inadequate in masking the taste of highly bitter drugs 1 . Complexation with Ion exchange resin (IER) provides alternative method for taste masking. In this method, weak acid anion exchange resin, Kyron T-134, was used for taste masking 2 . The drug resin complex is absolutely tasteless with no after taste, and at the same time, its bioavailability is not affected. AZT is orally absorbed drug used in the treatment or prevents certain bacterial infections, most often those causing middle ear infections, throat, pneumonia, typhoid, bronchitis and sinusitis 3 . Being highly bitter drug AZT posses a challenge particularly in the formulation of a pediatric dosage form.
*Corresponding author.
E-mail address: shetnikita@gmail.com (N.Shet) 2230-7842 / © 2013 JCPR. All rights reserved.
Materials and Methods

Materials
AZT was gift sample from CIPLA Ltd. Pharma R & D (India). Kyron T-134 was obtained as gift sample from Corel Pharma Chem., (Ahmedabad, India).
Sucrose, sorbitol, glycerine, xanthane gum, aerosil 200, sucralose , sodium methyl paraben, sodium propyl paraben, Butylated Hydroxy Toulene, menthol, Tween 80, and strawberry flavour was obtained from different manufacturers as gift sample. All other chemicals/solvents were of analytical grade. 4 A quantity 15 ml of distilled water was kept for stirring with the help of a magnetic stirrer. A weighed quantity of Kyron T -134 (3 times more than that of the drug) was added to the above water and stirred continuously for around 10 mins. AZT was added to the above solution under continuous stirring. After 20 minutes the pH was checked. The pH should be in between the range of 8.5 to 11 as the drug is stable in alkaline pH. If not in this range the pH had to be adjusted with 20% KOH solution and stirred for 1-2 hours. This wet complex was used for preparing the final suspension.
Preparation of AZT-Kyron T complex
Evaluation of AZT-Kyron T complex Molecular complex of drug resin complex
The IR spectra of AZT-Kyron T complex were recorded using Fourier transform infra-red spectrophotometer (IR Affinity -1 Fourier Transform Infrared Spectrophotometer Shimadzu). Sample preparation involved, drying of Potassium Bromide (KBr) in the oven to get rid of any moisture content then mixing the sample with KBr by triturating in glass mortar. Finally preparing of pellet and placing in the sample holder. The spectrum was scanned over a frequency range 4000-400 cm 
Taste Evaluation
The taste of complex was checked by panel method. The study protocol was explained and written consent was obtained from volunteers.
For this purpose 8 human volunteers were selected. Once placing the complex in the mouth for 60 seconds, bitterness recorded using a numerical scale. The numerical scale bears values as 0 = Good, 1 = Tasteless, 2 = slightly bitter, 3 = bitter, 4 = very bitter, which was determined by formulator. 
Preparation of AZT suspension
Viscosity of Suspension
The viscosity of suspension was determined at ambient condition, using Brookfield's viscometer with spindle no 3.with adequate amount of the sample. The release rate of Azithromycin Dihydrate Suspension was determined using USP dissolution testing apparatus II (paddle method). The dissolution test was performed using 900 ml of pH 6.8 Phosphate Buffer, at 37 ±0.5°C and 50 rpm. A sample (5 ml) of the solution was withdrawn from the dissolution apparatus at 0, 10, 15, 20, 30 and 45min, filtered. The samples were replaced with fresh dissolution medium of same quantity. Peak Area of these solutions was measured at 215 nm using a HPLC [8] system. Cumulative percentage of drug release was calculated using an equation obtained from a standard curve.
Scanning Electron Microscopy
The morphology of Azithromycin Dihydrate Suspension (Globules) prepared under the optimum condition was observed under scanning electron microscope.
Zeta Potential
Zeta potential is determined by using Zetasizer 7.Accelerated Stability Studies [10] Formulation batch BM2 of Azithromycin dihydrate Suspension, were packed individually in glass container in such a manner that any mechanical damage was minimal. These were then stored at following conditions, 1) Long term storage (25°C ± 2°C/60% RH ± 5% RH or30°C ± 2°C/65% RH ± 5% RH) for 3 months in glass dessicator containing Sodium nitrite at or30°C ± 2°C 2 ) Accelerated 40°C ± 2°C/75% RH ± 5% RH for 3 months ( in humidity controlled oven ) Suspension was examined for taste, Particle size, Viscosity, Sedimentation volume, In-vitro dissolution.
Results and Discussion
Evaluation of AZT-Kyron T complex IR Spectroscopy
In the FTIR spectrum of Kyron T -134-AZT complex new peaks appear at 2850 cm -1 , 992 cm -1 , 955 cm -1 which is not present in any of the components, thus a complex between AZT and Kyron T 134 is formed, which can be further confirmed by DSC analysis.
DSC (Differential Scanning Calorimeter)
The DSC melting curve of AZT showed a melting peak at 124. 
Drug entrapment efficiency
The percent drug entrapment efficiency was found to be 90%.
Taste Evaluation
The objective of this study is to conduct and evaluate the palatability of complex of AZTKyron T 134. When the batch of AZT-Kyron T 134 complex were evaluated by human volunteers, the volunteers did not feel any bitter taste after keeping the complex in the mouth for 60 seconds, which confirmed that the bitter taste of AZT was masked successfully. This is confirmed by the scale marking of the volunteers.
Evaluation of Taste Masked suspension
Sedimentation volume
The sedimentation volume can have values ranging from less than 1. The ultimate height of the solid phase after settling depends on the concentration of solid and the particle size. To obtain an acceptable suspension the value of F should be at least 0.9. In the present formulation there is little sedimentation after 14 days and it could be easily re dispersed to give a uniform dispersion after shaking for all the three batches.
Viscosity of Suspension
Sedimentation rate depends on the viscosity of the medium. From the sedimentation volume data, it can be seen that suspension is stable and re dispersible after 14 days. Thus, viscosity of the suspension is sufficient for the stability of the suspension. Particle size measurement The particle size remains reasonably constant after 14 days. The resin produces a swollen porous network structure that is capable of allowing the drug molecules to permeate/ diffuse inside and also get complexed with the resin. In Vitro Drug Release Studies AZT release from the suspension was observed in the average salivary pH of 6.8. The invitro drug release in the average salivary pH of 6.8 was about 90% within 45 minutes. The presence of exchangeable ions of ionizable electrolytes in the salivary fluid, followed by drug diffusion through the polymer matrix of the resonates may be responsible for this release. The drug-resin complex is stable in salivary pH for a period of administration. It also shows that the resin does not retard the release of drug from suspension. Table 4 . Viscosity of the suspension batches. Table 5 . Particle size of the suspension batches. 
Conclusion
Use of weak cation exchange resin offers superior method for preparing taste-masked substrates of AZT. A result obtained in this work shows that drug-resin complexes effectively masked bitter taste of AZT. While liquid formulation provides easier way to administer and getting the child to swallow. Also to overcome problem with noncompliance with child especially around 8 years old for whom swallowing other dosage form can be challenging.
